US set for all-electronic PMS reporting
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration (FDA) is proposing that all mandatory postmarket safety reporting to three of its centres, including the Center for Devices and Radiological Health (CDRH) and the Center for Biologics Evaluation and Research (CBER), be done only electronically.